Free Trial

Titan Pharmaceuticals (TTNP) Insider Trading & Ownership

Titan Pharmaceuticals logo
$3.75 +0.10 (+2.74%)
(As of 02:50 PM ET)

Titan Pharmaceuticals (NASDAQ:TTNP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.93%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$934,164.20
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$4.17 M
Get TTNP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Titan Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TTNP Insider Buying and Selling by Quarter

Titan Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/21/2023David E. LazarCEOSell169,445$24.60$4,168,347.00  
1/24/2023David E LazarCEOBuy1,875$19.40$36,375.00  
7/6/2022David E LazarMajor ShareholderBuy58,298$15.40$897,789.20  
(Data available from 1/1/2013 forward)

TTNP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Titan Pharmaceuticals includes David E Lazar. Learn more on insiders at TTNP.

24.93% of Titan Pharmaceuticals stock is owned by insiders. Learn more on TTNP's insider holdings.

The following insider purchased TTNP shares in the last 24 months: David E Lazar ($36,375.00).

Insiders have purchased a total of 1,875 TTNP shares in the last 24 months for a total of $36,375.00 bought.

The following insider sold TTNP shares in the last 24 months: David E. Lazar ($4,168,347.00).

Insiders have sold a total of 169,445 Titan Pharmaceuticals shares in the last 24 months for a total of $4,168,347.00 sold.

Titan Pharmaceuticals Key Executives

  • Mr. David Elliot Lazar (Age 33)
    CEO & Principal Financial Officer
    Compensation: $1.42M
  • Dr. Katherine L. Beebe-DeVarney Ph.D. (Age 63)
    President, COO & Director
    Compensation: $462k
  • Mr. Mike Fritz
    National Sales Director
  • Jennifer Kiernan
    Executive Assistant to CEO & Investor Communications Coordinator
  • Joe Schrei
    Executive Director of Commercial Operations


This page (NASDAQ:TTNP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners